Pre-publication history
A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
BMC Clinical Pathology 2013, 13:5 doi:10.1186/1472-6890-13-5
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 02 Oct 2012 | |
| Reviewer's Report | paul cottu | 10 Nov 2012 | |
| Reviewer's Report | Joel Parker | 14 Nov 2012 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 25 Dec 2012 |
| Reviewer's Report | Joel Parker | 05 Jan 2013 | |
| Reviewer's Report | paul cottu | 13 Jan 2013 | |
| Editorial acceptance | 30 Jan 2013 | ||
| Published | 06 Feb 2013 |
